We describe the endoscopic closure of a bronchial total fistula with the Occlutech Figulla ASD N device (International Occlutech AB, Helsingborg, Sweden), originally designed for closure of an atrial septal defect.
In this paper we introduce the concept of optimal experimental design and use it for finding an optimal test design for the closure determining method.
To our knowledge, this is the first study evaluating the feasibility of calculating value-based prices and providing recommendations for value-based product design for innovative closure devices.
It also introduces some important manufacturing technologies, semi-finished products as well as specific design concepts for closures.
We describe the successful treatment of a multidrug-resistant tuberculosis patient with BPF using an occlusion device originally designed for transcatheter closure of an atrial septal defect.
Background Different types of coils have been designed for transcatheter closure of persistent arterial ducts.
We successfully closed the fistula with an Amplatzer Septal Occluder (AGA Medical Corp, Plymouth, MN), a nitinol device designed for percutaneous closure of congenital heart defects.
The purpose of this study was therefore to assess the effect of bioactive coatings on biocompatibility of Nitinol coils designed for the closure of intra-atrial communications.
In this article, a new combined skin-subcutaneous tissue suturing technique called as "8-shaped crisscross tensile suture (8CTS)" designed for the closure of large skin defects is presented.
Surgical suture is a strand of biocompatible material designed for wound closure, and therefore can be a medical device potentially suitable for local drug delivery to treat pain at the surgical site.
In conclusion, r-hirudin and fibronectin coating, by causing no acute cytotoxicity, decreasing thrombogenicity and increasing endothelialisation improve in vitro biocompatibility of Nitinol devices designed for the closure of intra-atrial communications.
